Mondego Bio doses first humans with oral MB-388, an immunotherapy-resistance drug targeting the PTPN2/PTPN1 pathway. Phase 1a ...
Research shows that chronic stress can affect the immune system in several surprising ways.
BT-001, an armed oncolytic virus, enters Phase 1 clinical trial targeting pMMR rectal cancer — the 95% of patients who have ...
A previously unrecognized weakness in the immune defenses against certain blood neoplasms could offer a promising target for ...
A serial cross-sectional NHANES analysis of 7,920 U.S. adults found that five of six blood-derived inflammatory indices were ...
When plants encounter pathogens, they can defend themselves by rapidly killing infected cells to restrict pathogen spread.
How brain cancer cells change? AI reveals how glioblastoma cells change, opening new possibilities for brain cancer treatment ...
Experimental CAR-T cell therapy eliminated aggressive childhood brain tumours in mice and provided lasting immune protection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results